Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 500 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - radium-223 dichloride - solution for injection - radium-223 dichloride 1100 kbq/ml at reference date - radium (223 ra) dichloride - xofigo monotherapy or in combination with luteinising hormone releasing hormone (lhrh) analogue is indicated for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc), symptomatic bone metastases and no known visceral metastases, in progression after at least two prior lines of systemic therapy for advanced pc (other than lhrh analogues), or ineligible for any available systemic mcrpc treatment.

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - larotrectinib as sulfate - solution (oral) - larotrectinib as sulfate 20 mg/ml - larotrectinib - vitrakvi as monotherapy is indicated for the treatment of adult and paediatric patients with solid tumours that display a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,• who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, and• who have no satisfactory treatment options

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - finerenon - film coated tablets - finerenon 10 mg - finerenon - kerendia is indicated to reduce the risk of sustained egfr decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (ckd) associated with type 2 diabetes (t2d).

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - finerenon - film coated tablets - finerenon 20 mg - finerenon - kerendia is indicated to reduce the risk of sustained egfr decline, end-stage kidney disease, cardiovascular death, nonfatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (ckd) associated with type 2 diabetes (t2d).

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - iopromide - solution for injection - iopromide 623.4 mg / 1 ml - iopromide - iopromide - contrast enhancement in computerized tomography (ct) , digital subtraction angiography (dsa), intravenous urography, arteriography ,phlebography of the extremities, venography, visualization of body cavities (e.g. arthrography, hysterosalpingography,fistulography) with the exception of myelography, ventriculography, cisternography.

Israel - Tiếng Anh - Ministry of Health

bayer israel ltd - iopromide - solution for injection - iopromide 768.86 mg/ml - iopromide - iopromide - contrast enhancement in computerized tomography (ct) , digital subtraction angiography (dsa), intravenous urography, arteriography and especially angiocardiography, visualization of body cavities (e.g. arthrography, fistulography) with the exception of myelography, ventriculography, cisternography.